Although diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease, existing prognostic tools, including the revised International Prognostic Index (R-IPI) and the National Comprehensive Cancer Network (NCCN-IPI), do not fully capture the hete...
read more